Top Stories

  • Russian President Vladimir Putin said his country is the first to approve an experimental COVID-19 vaccine, a claim that is drawing criticism from outside scientists who say a vaccine that has been rushed through development and approval could be harmful to people or provide them with a false sense of security about being protected from infection. Putin said his own daughter has been inoculated with the vaccine, which has been dubbed Sputnik V in reference to the orbital satellite that launched the Soviet-U.S. space race in 1957. (The Washington Post)
  • The White House is considering a draft regulation that would temporarily prohibit a U.S. citizen or legal permanent resident from re-entering the United States from another country if authorities have reason to believe that the person has COVID-19. The Trump administration has previously passed rules to restrict foreigners’ access to the United States amid the coronavirus pandemic, but the new proposal does not appear to offer a timeframe as to how long a U.S. citizen or legal permanent resident who is believed to have contracted the virus would be required to remain outside of the country. (The New York Times)
  • Gilead Sciences Inc. is pursuing full approval for its experimental COVID-19 treatment remdesivir, which the Food and Drug Administration granted temporary emergency use authorization in May. Multiple regulatory bodies — including Australia, the European Union and Japan — have already approved remdesivir to treat COVID-19, and the United States has acquired almost all of the drug’s supply through September. (Reuters)

Chart Review

The Path to a Covid Vaccine
Bloomberg Businessweek

Events Calendar (All Times Local)

08/11/2020
STAT News event titled “How pharma is influencing the 2020 election” 1:00 pm
AHIP/IMB Watson Health webinar titled “Your Journey To Interoperability And Digital Transformation” 12:00 pm
08/12/2020
2020 CMS/ITU Outreach & Education
AHA Physician Alliance webinar titled “Stigma Kills – Addressing Opioid Use Disorder By Changing Culture” 12:00 pm
AHIP/FDA webinar titled “Safety and Savings With Biosimilars” 2:00 pm
08/13/2020
2020 CMS/ITU Outreach & Education
FDA: Meeting of the Oncologic Drugs Advisory Committee 8:00 am
Washington Post Live event titled “America’s Health Future” 11:00 am
National Geographic conversation titled “Stopping Pandemics” featuring Dr. Anthony Fauci and D.C. Mayor Muriel Bowser 1:00 pm
AdvaMed COVID-19 Return to Work Webinar: Managing Safety, Data and Privacy for a Secure Workplace 1:00 pm
View full calendar


Watch On-Demand – Most Loved Brands: What Drives Brand Love In A Year Like No Other

Recently, Morning Consult held a webinar breaking down the results in this year’s edition of Most Loved Brands.

Watch the webinar on-demand to learn which brands topped the list, what factors tend to drive brand love and how brands can excel in the COVID-19 era.

Coronavirus

Global coronavirus cases top 20 million
Nathaniel Weixel, The Hill

Global coronavirus cases topped 20 million, according to Johns Hopkins University data, with the United States, Brazil and India accounting for more than half of those infections.

5 states set single-day coronavirus case records last week
Orion Rummler, Axios

Five states set new highs last week for coronavirus infections recorded in a single day, according to the COVID Tracking Project and state health departments. Only one state — North Dakota — surpassed a record set the previous week.

Health officials are quitting or getting fired amid outbreak
Michelle R. Smith and Lauren Weber, The Associated Press

Vilified, threatened with violence and in some cases suffering from burnout, dozens of state and local public health leaders around the U.S. have resigned or have been fired amid the coronavirus outbreak, a testament to how politically combustible masks, lockdowns and infection data have become.

Why you should be skeptical of Russia’s coronavirus vaccine claims
Shane Savitsky and Rebecca Falconer, Axios

Scientists around the world are skeptical about Russia’s claims. There is no published scientific data to back up Putin’s claims that Russia has a viable vaccine — or that it produces any sort of immunity without significant side effects.

Coronavirus breaks out again in New Zealand after 102 days
Nick Perry, The Associated Press

New Zealand Prime Minister Jacinda Ardern said Tuesday that authorities have found four cases of the coronavirus in one Auckland household from an unknown source, the first reported cases of local transmission in the country in 102 days.

Payers

Costs higher for those who enroll on the ACA’s exchanges during special enrollment periods: study
Paige Minemyer, FierceHealthcare

People who sign up for individual market plans during special enrollment periods face higher costs than those who sign up for coverage during open enrollment, a new study shows.

Providers

Over 900 Health Workers Have Died of COVID-19. And the Toll Is Rising.
Danielle Renwick, The Guardian, and Shoshana Dubnow, Kaiser Health News

More than 900 front-line health care workers have died of COVID-19, according to an interactive database unveiled by The Guardian and KHN. Lost on the Frontline is a partnership between the two newsrooms that aims to count, verify and memorialize every U.S. health care worker who dies during the pandemic.

New York’s true nursing home death toll cloaked in secrecy
Bernard Condon et al., The Associated Press

Riverdale Nursing Home in the Bronx appears, on paper, to have escaped the worst of the coronavirus pandemic, with an official state count of just four deaths in its 146-bed facility. The truth, according to the home, is far worse: 21 dead, most transported to hospitals before they succumbed.

For Doctors of Color, Microaggressions Are All Too Familiar
Emma Goldberg, The New York Times

When Dr. Onyeka Otugo was doing her training in emergency medicine, in Cleveland and Chicago, she was often mistaken for a janitor or food services worker even after introducing herself as a doctor. She realized early on that her white male counterparts were not experiencing similar mix-ups.

Inside the Fight to Save Houston’s Most Vulnerable
Sheri Fink et al., The New York Times

As coronavirus infections surged in Texas this summer, Houston Methodist Hospital opened one intensive care unit after another for the most critically ill. We had unique access to one of the I.C.U.s, where many patients or their families gave us permission to follow their care.

Pharma, Biotech and Devices

Novavax expects it can meet U.S. COVID-19 vaccine demand in 2021, executives say
Carl O’Donnell and Abhijith G, Reuters

Novavax Inc’s manufacturing capacity is sufficient to meet the U.S. demand for COVID-19 vaccines in 2021, which it believes could be as high as 500 million to 600 million doses, company executives said on Monday.

Bayer Signs $875 Million Deal to Buy Women’s Health Biotech
Tim Loh, Bloomberg

Bayer AG struck an $875 million deal to acquire British women’s health biotech Kandy Therapeutics Ltd., bolstering its pharmaceuticals division before patents expire on some key products.

Moderna reveals it may not hold patent rights for coronavirus vaccine
Bob Herman, Axios

Moderna said in new financial filings that it “cannot be certain that we were the first to make the inventions claimed in our patents or pending patent applications” — including the company’s experimental coronavirus vaccine.

Moderna Wants to Transform the Body Into a Vaccine-Making Machine
Robert Langreth and Naomi Kresge, Bloomberg Businessweek

The coronavirus vaccines from Moderna Inc., in Cambridge, Mass., and its German rival BioNTech SE propose to immunize people in a radically different way: by harnessing human cells to become miniature vaccine factories in their own right. Instead of virus proteins, the vaccines contain genetic instructions that prompt the body to produce them. Those instructions are carried via messenger RNA, or mRNA.

Antibody drugs could be one of the best weapons against Covid-19. But will they matter?
Matthew Herper and Adam Feuerstein, Stat News

Scott Gottlieb, the former commissioner of the Food and Drug Administration, is less sure antibody treatments will be significant factors in bringing the pandemic under control. Even though the development efforts have been proceeding extraordinarily fast by normal standards, the U.S. has spent billions of dollars purchasing vaccines in advance, but has not done far less to shore up capacity for antibody drugs.

Health IT

Epic, Cerner, Allscripts vary in return-to-office approach
Jessica Kim Cohen, Modern Healthcare

While some electronic health record system developers are pushing for a return to in-person work, others are following the lead of big tech companies and evaluating whether remote work options could extend beyond the COVID-19 pandemic.

Telemedicine shines during pandemic but will glow fade?
Tom Murphy, The Associated Press

Doctors scrambled to shift to telemedicine when the coronavirus hit the U.S earlier this year. Care providers like the Cleveland Clinic went from averaging 5,000 telemedicine visits a month before the pandemic to 200,000 visits just in April.

With Livongo’s arsenal of health devices, Teladoc is poised to move into remote monitoring
Erin Brodwin, Stat News

As part of its landmark $18.5 billion deal to buy Livongo, telehealth giant Teladoc Health is poised to inherit a set of devices that the chronic care company has used for years to turn mountains of patient data into easily digestible health advice.

Inspired by llamas’ unique antibodies, scientists create a potent anti-coronavirus molecule
Usha Lee Mcfarling, Stat News

Inspired by a unique kind of infection-fighting antibody found in llamas, alpacas, and other camelids, a research team at the University of California, San Francisco, has synthesized a molecule that they say is among the most potent anti-coronavirus compounds tested in a lab to date.

Opinions, Editorials and Perspectives

Don’t Let the Search for a COVID-19 Vaccine Hinder Solutions for Other Diseases
Byron Dorgan, Morning Consult

Too many Americans, worried about being infected by the coronavirus, are delaying or postponing medically necessary visits to their doctor to get needed tests, surgery and treatment for other serious diseases like cancer, heart disease and more. And, as the National Institutes of Health’s stark warning describes, that delay can be fatal to many patients.

Research Reports

Examining multimorbidity differences across racial groups: a network analysis of electronic medical records
Pankush Kalgotra et al., Scientific Reports

Health disparities across ethnic or racial groups are typically examined through single behavior at a time. The syndemics and multimorbidity health disparities have not been well examined by race.

General

Trump: Executive order on pre-existing conditions is ‘a signal’
Politico

President Donald Trump on Monday acknowledged a prospective executive order he’s considering to make insurers cover pre-existing conditions amounted to political messaging — and that Obamacare already offered such protections.

AAMC, the medical school trade association, gave $500,000 to dark-money group in 2018
Lev Facher, Stat News

The dark-money group Citizens for Truth in Drug Pricing, which has run several major anti-pharma campaigns on conservative radio shows, received significant funding from the Association of American Medical Colleges, according to a recent review of federal tax documents.

Morning Consult